Ana Pedrero Gil/LinkedIn
Jul 24, 2026, 04:53
Ana Pedrero Gil: The Future of Blood-Derived Therapies
Ana Pedrero Gil, Anesthesiologist at Igualada University Hospital, shared a post on LinkedIn about a recent article by Kerstin Wendland et al., published in Transfusion Medicine and Hemotherapy, adding:
“Donated blood is no longer used only as standard transfusion components but is increasingly being developed into new types of therapies.
This review explains recent progress in turning plasma, red blood cells (RBCs), platelets, donor stem cells, and cord blood into more advanced medical products.”
Title: From Donation to Innovation: New Blood-Derived Products
Authors: Kerstin Wendland, Kathleen Selleng, Konstanze Aurich
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke